Ondine Biomedical Inc. (AIM:OBI)
London flag London · Delayed Price · Currency is GBP · Price in GBX
10.50
-0.50 (-4.76%)
Jun 13, 2025, 4:35 PM GMT+1

Ondine Biomedical Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
47362040108-
Upgrade
Market Cap Growth
79.20%79.20%-50.26%-63.06%--
Upgrade
Enterprise Value
41351827127-
Upgrade
Last Close Price
0.100.090.090.200.56-
Upgrade
PS Ratio
40.9331.2627.74101.9672.03-
Upgrade
PB Ratio
12.209.3116.015.596.24-
Upgrade
P/TBV Ratio
12.209.3116.015.596.24-
Upgrade
EV/Sales Ratio
36.2530.8224.9069.7484.97-
Upgrade
Debt / Equity Ratio
0.020.020.260.120.02-1.04
Upgrade
Asset Turnover
0.220.220.110.030.14-
Upgrade
Inventory Turnover
0.620.620.420.301.80-
Upgrade
Quick Ratio
1.731.730.953.417.810.03
Upgrade
Current Ratio
2.052.051.363.878.540.05
Upgrade
Return on Equity (ROE)
-426.20%-426.20%-209.95%-93.81%--
Upgrade
Return on Assets (ROA)
-130.98%-130.98%-82.98%-46.25%-59.55%-
Upgrade
Return on Capital (ROIC)
-251.32%-251.32%-118.27%-54.06%-69.33%-
Upgrade
Earnings Yield
-22.77%-29.82%-43.18%-29.78%-27.07%-
Upgrade
FCF Yield
-18.48%-24.20%-41.44%-25.60%-6.82%-
Upgrade
Buyback Yield / Dilution
-39.31%-39.31%-1.30%-144.34%-12.69%-761.95%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.